SCHEMBL30442407

SCHEMBL30442407

Cc1cc(N)c(C#Cc2ccc(S(=O)(=O)C3CC3)cc2)c(C)n1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 3/20 0.35
▸ CA1 P00915 3/20 0.35
▸ CA2 P00918 3/20 0.35
▸ CA9 Q16790 3/20 0.35
▸ MTOR P42345 2/20 0.33
▸ ATM Q13315 1/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ MMP13 P45452 1/20 0.33
▸ HRH4 Q9H3N8 2/20 0.32
▸ CCR6 P51684 2/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ ADAM17 P78536 1/20 0.31
▸ MMP2 P08253 1/20 0.31
▸ MMP9 P14780 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26381069 0.88 CA12 (0.34) CA12CA1CA2CA9MTOR
SCHEMBL29395755 0.88 CA12 (0.34) CA12CA1CA2CA9MTOR
SCHEMBL26072377 0.68 MMP13 (0.41) CA12CA1CA2CA9MMP13
SCHEMBL26381068 0.66 CA12 (0.53) CA12CA1CA2CA9MMP13
SCHEMBL21014310 0.65 ALDH1A1 (0.41) CA12CA1CA2CA9MMP13
SCHEMBL12241625 0.65 ALDH1A1 (0.42) CA12CA1CA2CA9MMP13
SCHEMBL2149410 0.63 TSHR (0.52) CA12CA1CA2CA9MMP13
SCHEMBL5761130 0.63 GAA (0.52) CA12CA1CA2CA9MMP13
SCHEMBL26384171 0.63 MMP13 (0.38) CA12CA1CA2CA9MMP13
SCHEMBL5020942 0.62 CA12 (0.36) CA12CA1CA2CA9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115867549-A 1H-pyrrolo [3,2-c ] pyridine and 1H-pyrrolo [2,3-c ] pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis 百时美施贵宝公司 2023-03-28 — — CN disclosed
Send feedback